Home › Research › Brain tissue and pathology
Association of Leucocyte Telomere Length With Stroke, Dementia, and Late-Life Depression
Tamara N. Kimball, Savvina Prapiadou, Reinier W. P. Tack, Benjamin Yong‐Qiang Tan, Jasper Rudolf Senff, Christina E. Kourkoulis, Sanjula Singh, Jonathan M. Rosand et al.. Neurology, 2025-06-11
Topic: Brain proteins, microglia and lab models
Plain-language summary
The study included 356,173 participants (median age 56 years; 53.69% female). Shorter LTL was consistently associated with higher incidence rates across all outcomes. Participants in the shortest LTL tertile had elevated risks of the composite outcome (hazard ratio [HR] 1.11; 95% CI 1.08-1.15), stroke (HR 1.08; 95% CI 1.02-1.15), dementia (HR 1.19; 95% CI 1.12-1.26), and LLD (HR 1.14; 95% CI 1.09-1.18). Individuals with both shorter LTL and lower BCS faced significantly increased risks of age-related brain diseases (HR 1.11; 95% CI 1.07-1.16) and individually for stroke (HR 1.10; 95% CI 1.02-1.19), dementia (HR 1.17; 95% CI 1.08-1.28), and LLD (HR 1.13; 95% CI 1.07-1.19). Conversely, individuals with higher BCS within the shortest LTL group did not show a significant increase in risk of any age-related brain diseases. MR analyses did not identify causal relationships between LTL and these outcomes. Individuals with shorter LTL are at increased risk of stroke, dementia, and LLD. Improved modifiable risk factor profiles seem to mitigate the impact of LTL on these diseases. Future research should explore the effectiveness of lifestyle interventions in mitigating adverse biological aging effects on brain health.
What this study adds
Evidence grade: Low
The record lists 356,173 participants. In 356,173 participants, shorter leucocyte telomere length was associated with higher incidence of stroke, dementia and late-life depression, but Mendelian randomization analyses did not identify causal relationships between telomere length and these outcomes. Reported effect size: 53.69%; HR 1.08; HR 1.19.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Kimball, T. N., Prapiadou, S., Tack, R. W. P., Tan, B. Y., Senff, J. R., Kourkoulis, C. E., et al. (2025). Association of Leucocyte Telomere Length With Stroke, Dementia, and Late-Life Depression. Neurology. https://doi.org/10.1212/wnl.0000000000213794
Vancouver
Kimball TN, Prapiadou S, Tack RWP, Tan BY, Senff JR, Kourkoulis CE, et al. Association of Leucocyte Telomere Length With Stroke, Dementia, and Late-Life Depression. Neurology. 2025. doi:10.1212/wnl.0000000000213794. PMID: 40499086.
BibTeX
@article{kimball2025-40499086,
author = {Kimball, Tamara N. and Prapiadou, Savvina and Tack, Reinier W. P. and Tan, Benjamin Yong‐Qiang and Senff, Jasper Rudolf and Kourkoulis, Christina E. and Singh, Sanjula and Rosand, Jonathan M. and others},
title = {{Association of Leucocyte Telomere Length With Stroke, Dementia, and Late-Life Depression}},
journal = {Neurology},
year = {2025},
doi = {10.1212/wnl.0000000000213794},
pmid = {40499086},
url = {https://doi.org/10.1212/wnl.0000000000213794}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- The study included 356,173 participants (median age 56 years; 53.69% female).
- Shorter LTL was consistently associated with higher incidence rates across all outcomes.
- Participants in the shortest LTL tertile had elevated risks of the composite outcome (hazard ratio [HR] 1.11; 95% CI 1.08-1.15), stroke (HR 1.08; 95% CI 1.02-1.15), dementia (HR 1.19; 95% CI 1.12-1.26), and LLD (HR 1.14; 95% CI 1.09-1.18).
- Individuals with both shorter LTL and lower BCS faced significantly increased risks of age-related brain diseases (HR 1.11; 95% CI 1.07-1.16) and individually for stroke (HR 1.10; 95% CI 1.02-1.19), dementia (HR 1.17; 95% CI 1.08-1.28), and LLD (HR 1.13; 95% CI 1.07-1.19).
- Conversely, individuals with higher BCS within the shortest LTL group did not show a significant increase in risk of any age-related brain diseases.
Why it matters
In 356,173 participants, shorter leucocyte telomere length was associated with higher incidence of stroke, dementia and late-life depression, but Mendelian randomization analyses did not identify causal relationships between telomere length and these outcomes. The study reports associations only and does not test any treatment, cure or prevention.
Study details
- Participants356,173
- Effect size53.69%; HR 1.08; HR 1.19
- Evidence strengthLow
How this study scored 57/100
Published in a leading specialty journal. Scored zero for study design and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Neurology) |
| Journal's citation record | 4 / 4 | Neurology: journal h-index 525 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 4 / 4 | 356,173 participants |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 6 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 2.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 3 / 6 | Cited 3.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 6 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Christopher D. Anderson: h-index 65 (OpenAlex, whole career) |
| Institution's track record | 3 / 3 | Broad Institute: institution h-index 2,541 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 8 institution(s) in 3 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40499086) |
| Free to read | 2 / 2 | Free to read |
| Total | 57 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1212/wnl.0000000000213794
- PubMed: 40499086
- Original source →
- Free full text: Utrecht University Repository (Utrecht University) →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Brain tissue and pathology from nearby years
Also tagged “tdp-43”
1,150 studies in the library carry the topic tag “tdp-43”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,150 tagged studies.